Zdrowie i gospodarka · 30/03/2004
FDA Releases Draft Guidance on Comparability of Biotech Products After Manufacturing Process Changes
The FDA has made available a draft guidance document, prepared by the International Conference on Harmonisation, to help assess the impact of manufacturing process changes on the quality, safety, and efficacy of biotech products.
Source: Federal Register — Food and Drug AdministrationOpen original release →